研究者

J-GLOBAL ID：201701015939615987 更新日: 2020年09月01日

西野将矢

ニシノ | Masaya Nishino

所属機関・部署：

研究分野 (1件)：呼吸器外科学

研究キーワード (3件)：呼吸器外科 , 分子標的治療薬 , 肺癌

論文 (16件)：

Masaya Nishino, Kenichi Suda, Yoshihisa Kobayashi, Shuta Ohara, Toshio Fujino, Takamasa Koga, Masato Chiba, Masaki Shimoji, Kenji Tomizawa, Toshiki Takemoto, et al. Effects of secondary EGFR mutations on resistance against upfront osimertinib in cells with EGFR-activating mutations in vitro. Lung cancer (Amsterdam, Netherlands). 2018. 126. 149-155
Takamasa Koga, Yoshihisa Kobayashi, Kenji Tomizawa, Kenichi Suda, Takayuki Kosaka, Yuichi Sesumi, Toshio Fujino, Masaya Nishino, Shuta Ohara, Masato Chiba, et al. Activity of a novel HER2 inhibitor, poziotinib, for HER2 exon 20 mutations in lung cancer and mechanism of acquired resistance: An in vitro study. Lung cancer (Amsterdam, Netherlands). 2018. 126. 72-79
Junji Kawada, Masaya Nishino, Tomoki Hata, Keiko Tanizaki, Takayuki Ogino, Hiromitsu Hoshino, Miho Okano, Kenichi Nagai, Yongkook Kim, Masaki Okuyama, et al. [Analysis of Patients Who Received Nutritional Support and the Enhanced Recovery after Surgery(ERAS)Protocol after Esophagectomy]. Gan to kagaku ryoho. Cancer & chemotherapy. 2018. 45. 10. 1524-1526
Yoshihisa Kobayashi, Toshio Fujino, Masaya Nishino, Takamasa Koga, Masato Chiba, Yuichi Sesumi, Shuta Ohara, Masaki Shimoji, Kenji Tomizawa, Toshiki Takemoto, et al. EGFR T790M and C797S Mutations as Mechanisms of Acquired Resistance to Dacomitinib. Journal of Thoracic Oncology. 2018. 13. 5. 727-731
Junji Kawada, Masaya Nishino, Tomoki Hata, Takayuki Ogino, Masateru Okawa, Hiromitsu Hoshino, Miho Okano, Kenichi Nagai, Naruyasu Kakita, Yongkook Kim, et al. [A Case of Advanced Esophageal Cancer Successfully Treated with Multidisciplinary Therapy]. Gan to kagaku ryoho. Cancer & chemotherapy. 2018. 45. 4. 703-705

もっと見る

MISC (19件)：

もっと見る

学歴 (1件)：

- 2011 近畿大学医学部医学科卒業

※　J-GLOBALの研究者情報は、researchmapの登録情報に基づき表示しています。登録・更新については、こちらをご覧ください。

前のページに戻る

TOP